SCHEMBL3090187

SCHEMBL3090187

COc1ccc2ccn(C(=O)c3cc(F)cc(F)c3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 1/20 0.56
TFPI2 P48307 1/20 0.47
MTNR1A P48039 5/20 0.44
MTNR1B P49286 5/20 0.44
AKR1C3 P42330 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
FABP4 P15090 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CPS1 P31327 1/20 0.41
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTR6 P50406 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28409121 0.78 MTNR1A (0.55) TUBB1TFPI2MTNR1AMTNR1BALDH1A1
SCHEMBL5569918 0.78 TFPI2 (0.57) TUBB1TFPI2MTNR1AMTNR1BAKR1C3
SCHEMBL30297606 0.78 TFPI2 (0.57) TUBB1TFPI2MTNR1AMTNR1BAKR1C3
SCHEMBL3917906 0.76 TUBB1 (0.76) TUBB1TFPI2MTNR1AMTNR1BAKR1C3
SCHEMBL28661147 0.76 TFPI2 (0.52) TUBB1TFPI2MTNR1AMTNR1BTRPV1
SCHEMBL20905149 0.73 TFPI2 (0.50) TUBB1TFPI2MTNR1AMTNR1BMEN1
SCHEMBL2117429 0.73 MTNR1A (0.51) TUBB1TFPI2MTNR1AMTNR1BALDH1A1
SCHEMBL6331989 0.73 MAPT (0.51) TUBB1TFPI2MTNR1AALDH1A1FABP4
SCHEMBL982760 0.72 TFPI2 (0.49) TUBB1TFPI2MTNR1AMTNR1BTRPV1
SCHEMBL3919337 0.72 TUBB1 (1.00) TUBB1TFPI2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795280-B2 Indoles useful in the treatment of androgen-receptor related diseases N.V. ORGANON (NL) 2010-09-14 US disclosed
US-20060128722-A1 Indoles useful in the treatment of androgen-receptor related diseases AKZO NOBEL N.V. (NL) 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128722-A1 Indoles useful in the treatment of androgen-receptor related diseases AR, NR5A1, SHBG TUBB1 737/4885TFPI2 2827/4885MTNR1A 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.